Connect Sign In
LabMind podcasts
ARUP’s assay is the first commercially available reference test that both detects the measles virus and distinguishes between vaccine-related and wild-type strains of the virus. |
January 23, 2026 |
Dual-Target Molecular Measles Virus Assay Aids Response to Ongoing Outbreaks ARUP Laboratories’ dual-target molecular measles virus assay provides a highly sensitive, specific, and rapid assay to aid the public health response to ongoing measles outbreaks. |
James Hadley, CISSP, joined ARUP as chief information security officer (CISO) in July 2025 after having served as CISO for the U.S. Department of Health and Human Services (HHS) Administration for Strategic Preparedness and Response (ASPR). |
January 7, 2026 |
Chief Information Security Officer Brings Vast Federal and Healthcare Experience to ARUP James Hadley, CISSP, chief information security officer, brings 25 years of cybersecurity experience to ARUP with a focus on risk management, collaboration, and building a resilient security culture. |
A microbiologist, Adam Barker, PhD, was ARUP's chief scientific officer and director of Research and Development before being named chief operations officer. He now adds Reference Business Unit president to his title. |
December 23, 2025 |
Adam Barker, PhD, Named President and Chief Operations Officer of ARUP Reference Business Unit In his new role, Adam Barker, PhD, will lead operational innovation to support ARUP’s growth while maintaining the highest quality. |
ARUP’s Robert Ohgami, MD, PhD, MBA, FCAP, gave a poster presentation detailing novel research on AI-driven grading of Castleman disease histopathology. |
December 8, 2025 |
ARUP Experts Contributed to Castleman Disease Research Showcased by Recordati at ASH Annual Meeting RIDGEWATER, N.J.—Recordati Rare Diseases Inc. today announced the presentation of new data detailing advances in the understanding of Castleman disease (CD), a group of rare immune system disorders characterized by abnormal lymph node enlargement and systemic inflammatory symptoms that can be potentially life threatening. |
Tracy George, MD, ARUP chief scientific officer and Innovation Business Unit president, will serve on the Board of Directors for BioUtah starting in January. |
December 4, 2025 |
Tracy George, MD, ARUP CSO and Innovation Business Unit President, Joins BioUtah Board Tracy George, MD, ARUP chief scientific officer and Innovation Business Unit president, will help advance life sciences innovation and strengthen Utah’s healthcare ecosystem with BioUtah. |
Visit ARUP at booth #1180 to connect with our experts, learn about the latest in testing for blood disorders, and test your diagnostic skills. |
December 2, 2025 |
ARUP Experts Will Showcase Their Latest Research at the ASH Annual Meeting and Exposition ARUP experts will showcase their latest research at the ASH Annual Meeting and Exposition, including updates on key clinical trials and the development of automated disease scoring. |
ARUP Institute for Research and Innovation in Diagnostic and Precision Medicine™ We accelerate the development and adoption of cutting-edge diagnostic and prognostic technologies advancing patient care through groundbreaking science and engineering. The Sherrie Perkins Research and Innovation Collaboration Grant The Sherrie Perkins Research and Innovation Collaboration Grant funds cutting-edge research in laboratory medicine.
ARUP Newsroom
Live Chat